BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 35209864)

  • 1. A core outcome set for randomised controlled trials of physical activity interventions: development and challenges.
    Crocker H; Peters M; Foster C; Black N; Fitzpatrick R
    BMC Public Health; 2022 Feb; 22(1):389. PubMed ID: 35209864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Core Rehabilitation Outcome Set for Single-Sided Deafness (CROSSSD) study: International consensus on outcome measures for trials of interventions for adults with single-sided deafness.
    Katiri R; Hall DA; Hoare DJ; Fackrell K; Horobin A; Hogan N; Buggy N; Van de Heyning PH; Firszt JB; Bruce IA; Kitterick PT;
    Trials; 2022 Sep; 23(1):764. PubMed ID: 36076299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A core domain set for pyoderma gangrenosum trial outcomes: an international eDelphi and consensus study from the UPGRADE initiative.
    Jacobson ME; Rick JW; Gerbens LAA; Baghoomian W; Gould LJ; Marzano AV; Chen DM; Oakes DL; Dissemond J; Yamamoto T; Shinkai K; Nolan B; Lobato D; Thomas KS; Ortega-Loayza AG;
    Br J Dermatol; 2024 Feb; 190(3):392-401. PubMed ID: 37952167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a standardised set of metrics for monitoring site performance in multicentre randomised trials: a Delphi study.
    Whitham D; Turzanski J; Bradshaw L; Clarke M; Culliford L; Duley L; Shaw L; Skea Z; Treweek SP; Walker K; Williamson PR; Montgomery AA;
    Trials; 2018 Oct; 19(1):557. PubMed ID: 30326967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developing a core outcome set for physical activity interventions in primary schools: a modified-Delphi study.
    Ram B; Foley KA; van Sluijs E; Hargreaves DS; Viner RM; Saxena S
    BMJ Open; 2022 Sep; 12(9):e061335. PubMed ID: 36180126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A core outcome domain set for clinical research on capillary malformations (the COSCAM project): an e-Delphi process and consensus meeting.
    Langbroek GB; Wolkerstorfer A; Horbach SER; Spuls PI; Kelly KM; Robertson SJ; van Raath MI; Al-Niaimi F; Kono T; Boixeda P; Laubach HJ; Badawi AM; Rubin AT; Haedersdal M; Manuskiatti W; van der Horst CMAM; Ubbink DT;
    Br J Dermatol; 2022 Nov; 187(5):730-742. PubMed ID: 35762296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methodology in core outcome set (COS) development: the impact of patient interviews and using a 5-point versus a 9-point Delphi rating scale on core outcome selection in a COS development study.
    Remus A; Smith V; Wuytack F
    BMC Med Res Methodol; 2021 Jan; 21(1):10. PubMed ID: 33413129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Core Domains for Research on Hospital Inactivity in Acutely Ill Older Adults: A Delphi Consensus Study.
    Baldwin CE; Phillips AC; Edney SM; Lewis LK
    Arch Phys Med Rehabil; 2021 Apr; 102(4):664-674. PubMed ID: 33253693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a core outcome set for use in research evaluations of interventions for venous leg ulceration: International eDelphi consensus.
    Hallas S; Nelson EA; O'Meara S; Gethin G;
    J Tissue Viability; 2024 May; 33(2):324-331. PubMed ID: 38594148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a Core Outcome Set for Clinical Trials in Non-infectious Uveitis of the Posterior Segment.
    Tallouzi MO; Mathers JM; Moore DJ; Bucknall N; Calvert MJ; Murray PI; Denniston AK;
    Ophthalmology; 2021 Aug; 128(8):1209-1221. PubMed ID: 33515595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selecting Core Outcomes for Randomised Effectiveness trials In Type 2 diabetes (SCORE-IT): a patient and healthcare professional consensus on a core outcome set for type 2 diabetes.
    Harman NL; Wilding JPH; Curry D; Harris J; Logue J; Pemberton RJ; Perreault L; Thompson G; Tunis S; Williamson PR;
    BMJ Open Diabetes Res Care; 2019; 7(1):e000700. PubMed ID: 31908789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a core outcome set for trials on induction of labour: an international multistakeholder Delphi study.
    Dos Santos F; Drymiotou S; Antequera Martin A; Mol BW; Gale C; Devane D; Van't Hooft J; Johnson MJ; Hogg M; Thangaratinam S
    BJOG; 2018 Dec; 125(13):1673-1680. PubMed ID: 29981523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Core Outcome Set for IgE-mediated food allergy clinical trials and observational studies of interventions: International Delphi consensus study 'COMFA'.
    Demidova A; Drewitz KP; Kimkool P; Banjanin N; Barzylovich V; Botjes E; Capper I; Castor MAR; Comberiati P; Cook EE; Costa J; Chu DK; Epstein MM; Galvin AD; Giovannini M; Girard F; Golding MA; Greenhawt M; Ierodiakonou D; Jones CJ; Khaleva E; Knibb RC; Macit-Çelebi MS; Mack DP; Mafra I; Marchisotto MJ; Mijakoski D; Nekliudov N; Özdemir C; Patel N; Pazukhina E; Protudjer JLP; Rodríguez Del Rio P; Roomet J; Sammut P; Schoos AM; Schopfer AF; Schultz F; Seylanova N; Skypala I; Sørensen M; Stoleski S; Stylianou E; Upton J; van de Veen W; Genuneit J; Boyle RJ; Apfelbacher C; Munblit D;
    Allergy; 2024 Apr; 79(4):977-989. PubMed ID: 38433402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Core Outcome Domains for early phase clinical trials of sound-, psychology-, and pharmacology-based interventions to manage chronic subjective tinnitus in adults: the COMIT'ID study protocol for using a Delphi process and face-to-face meetings to establish consensus.
    Fackrell K; Smith H; Colley V; Thacker B; Horobin A; Haider HF; Londero A; Mazurek B; Hall DA
    Trials; 2017 Aug; 18(1):388. PubMed ID: 28835261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Core outcome domains for clinical trials in non-specific low back pain.
    Chiarotto A; Deyo RA; Terwee CB; Boers M; Buchbinder R; Corbin TP; Costa LO; Foster NE; Grotle M; Koes BW; Kovacs FM; Lin CW; Maher CG; Pearson AM; Peul WC; Schoene ML; Turk DC; van Tulder MW; Ostelo RW
    Eur Spine J; 2015 Jun; 24(6):1127-42. PubMed ID: 25841358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Core outcome set measurement for future clinical trials in acute myeloid leukemia: the HARMONY study protocol using a multi-stakeholder consensus-based Delphi process and a final consensus meeting.
    Lang KM; Harrison KL; Williamson PR; Huntly BJP; Ossenkoppele G; Geissler J; Bereczky T; Hernández-Rivas JM; Chevrou-Séverac H; Goodbody R; Schulze-Rath R; Bullinger L
    Trials; 2020 May; 21(1):437. PubMed ID: 32460828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Core outcome domains for lichen sclerosus: a CORALS initiative consensus statement.
    Simpson RC; Kirtschig G; Selk A; von Seitzberg S; Vittrup G; Bissonnette I; Kottner J; Lanthier J; Stanton C; Foster D; Promm M; Augenti A; Lauretti S; Thomas KS;
    Br J Dermatol; 2023 Apr; 188(5):628-635. PubMed ID: 36702803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An international multi-stakeholder delphi consensus exercise to develop a core outcomes set (COS) for surgical fixation of rib fractures.
    Ingoe HMA; Eardley W; Rangan A; Hewitt C; McDaid C
    Injury; 2020 Feb; 51(2):224-229. PubMed ID: 31679833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying a Core Domain Set to Assess Psoriasis in Clinical Trials.
    Callis Duffin K; Merola JF; Christensen R; Latella J; Garg A; Gottlieb AB; Armstrong AW
    JAMA Dermatol; 2018 Oct; 154(10):1137-1144. PubMed ID: 29874367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Core Outcome Set for Actinic Keratosis Clinical Trials.
    Reynolds KA; Schlessinger DI; Vasic J; Iyengar S; Qaseem Y; Behshad R; DeHoratius DM; Denes P; Drucker AM; Dzubow LM; Etzkorn JR; Harwood C; Kim JYS; Lee EH; Lissner GS; Marghoob AA; Matin RN; Mattox A; Mittal BB; Thomas JR; Zhou XA; Zloty D; Schmitt J; Kirkham J; Poon E; Sobanko JF; Cartee TV; Maher IA; Alam M
    JAMA Dermatol; 2020 Mar; 156(3):326-333. PubMed ID: 31939999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.